
Is this your show? Claim this page
PodCred
The people behind this show
People get invited back because someone remembered they were great.
PodCred is the verified record of who made this show. A credit here means people who were there confirmed the work.
Hosts
Who is on this show?
Think of the guest you still think about. The producer who makes the host sound smart. The editor who saves every episode. If a name is missing here, that person is invisible everywhere.
Add a creditEpisodes
124 episodesHow Will the EU JCA Reshape National HTA Across Europe, Dr. Oriol Solà-Morales?
Is the EU Joint Clinical Assessment just another administrative layer, or the start of a truly European HTA? In this MAP episode, Dr. Stefan Walzer talks with Dr. Oriol Solà-Morales, physician, health economist, founder...
How Can HEOR Teams Build Trust in AI-Generated Models, Haidong Feng?
AI is reshaping health economics and outcomes research (HEOR) - but where does it truly belong? In this MAP episode, Dr. Stefan Walzer talks with Haidong Feng, Associate Principal Scientist at Merck, about “human in the...
Can US GLOBE and GUARD Models Really Lower Drug Prices, Brittany La Couture?
When the US benchmarks drug prices against other countries, the whole world feels it. In this episode of MAP - the Market Access Podcast, Dr. Stefan Walzer sits down with Brittany La Couture of Applied Policy, a health...
What Will It Take to Keep Biotech Growing in Europe, Rainer Westermann?
In this episode of MAP - the Market Access Podcast, Dr. Stefan Walzer sits down with Rainer Westermann, Chairman of the Life Sciences Acceleration Alliance (LSAA), to ask whether Europe can remain a globally competitive...
How Do You Build a High-Performing Team in Pharma, Dr. Maurice Kléber?
In this episode of MAP - the Market Access Podcast, Dr. Stefan Walzer sits down with Dr. Maurice Kléber to explore what building a winning team really takes - drawing on 18 years of leadership and a shared love of ice...
Where Does AI Really Add Value in Market Access, Dr. Seye Abogunrin?
Everyone wants AI to click the button for them - the real question is whether you still need to click it at all. In this episode of MAP - the Market Access Podcast, Dr. Stefan Walzer sits down with Dr. Seye Abogunrin, a...
Why Should Early Health Economics Move Upstream, Dr. Björn Schwander & Julie Frappier?
By the time most health economists get pulled in, the recipe is already set. In this episode of MAP - the Market Access Podcast, Dr. Stefan Walzer sits down with two industry veterans - Dr. Björn Schwander, Founder of...
How Are Data Privacy Laws Delaying Patient Access to New Treatments, Douglas Drake and Adam Skali? (Repost)
This is a repost of a popular episode of MAP - Market Access Podcast, from March 1st 2025. In this episode of MAP, Dr. Stefan Walzer, together with experts Douglas Drake and Adam Skali, unpacks the complexities of how...
How Did MFN Turn Swiss Pricing into an Industrial Policy Problem, Dr. Marcel Boller?
When Bern sets a price, Washington now listens. In this episode of MAP - the Market Access Podcast, Dr. Stefan Walzer sits down with Dr. Marcel Boller, Pharma and Medtech Expert and Partner at Werder Viganò in Zurich,...
Is the EU "Launch Obligation" Really as Scary as It Sounds, Dr. Alexander Natz?
In the latest episode of MAP - the Market Access Podcast, Dr. Stefan Walzer sits down with Dr. Alexander Natz, Secretary-General of EUCOPE, to unpack the biggest regulatory shifts reshaping pharmaceutical market access...
Dynamic Rebates, Drug Tenders & AMNOG: Is Germany Rewriting the Rules for Pharma, Thomas Hammerschmidt?
Tune in to the newest episode of MAP, the Market Access Podcast, where Dr. Stefan Walzer engages in an insightful discussion with Prof. Dr. Thomas Hammerschmidt, a leading expert in Pharmaceutical Management at the...
Wie finanziert Deutschland Gesundheitsinnovation, ohne den Patientenzugang zu gefährden, Afschin Gandjour?
In der deutschsprachigen Spezialfolge des MAP - Market Access Podcast spricht Dr. Stefan Walzer mit Prof. Dr. Afschin Gandjour, Arzt, Gesundheitsökonom und Finanzexperte, über eine der zentralen gesundheitspolitischen...
What lessons can Market Access teams learn from an Olympic medalist, Livia Altmann?
From Olympic ice to AI-powered leadership: What can Market Access teams learn from elite sports? In the 111+1 anniversary episode of MAP - the Market Access Podcast, Dr. Stefan Walzer interviews Livia Altmann, a former...
How Are UK NICE and US IRA/MFN Rewriting Global Pharma Pricing, Sreeram Ramagopalan?
In the latest episode of MAP - the Market Access Podcast, Dr. Stefan Walzer speaks with Sreeram Ramagopalan, a global expert at the intersection of biotech value, HTA, real‑world evidence and market access. Together...
How Can Europe Move from Innovation Paradox to Powerhouse, Cuno Moser?
In the latest episode of MAP - the Market Access Podcast, Dr. Stefan Walzer engages with Swiss healthcare strategist Cuno Moser to explore Europe's "innovation paradox" in healthcare. Despite its strengths in research,...
Posts
No posts yet. Posts MAP - Market Access Podcast shares on PodSubs, and what it publishes on Substack, YouTube and its own site, will show here.

Subscribe
Be on the front line of the show
Everything MAP - Market Access Podcast sends its own people, first. Resources, announcements, behind the scenes, events, and giveaways, straight from the host. No account needed.
- The resources the host shares with subscribers
- Announcements before anyone else hears
- Behind the scenes from the team
- Events, invitations, and giveaways
- Only what the host sends, nothing else
Audio and video play straight from the show's own hosting. PodSubs stores and serves no media.
















